Who Paid My Doc
Phase P3 Pediatric Study (EM).
Research payments
$1,154,035
Through program year 2021, $1,154,035 in research payments was reported against Phase P3 Pediatric Study (EM)., across 167 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $495,544 | 46 |
| 2020 | Research | $658,491 | 121 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Marcy Yonker Aurora, CO Named on 11 payments
- Jack Gladstein Baltimore, MD Named on 10 payments
- Paul Winner West Palm Beach, FL Named on 10 payments
- Joel Saper Ann Arbor, MI Named on 9 payments
- Marc Disabella Washington, DC Named on 9 payments
- Nathan Bennett Pittsburgh, PA Named on 9 payments
- Andrew Hershey Cincinnati, OH Named on 8 payments
- Peter McAllister Fairfield, CT Named on 8 payments
- Jo Bonner St. Louis, MO Named on 8 payments
- Jennifer McVige Amherst, NY Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.